← Open Payments lookup

AMY HULSE: Open Payments

NPI 1396227211 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$649 in 39 payments from 9 companies in 2025. Trend: 2023 $609 · 2024 $782 · 2025 $649

Food & beverage: $649
CompanyPaymentsAmount
GENZYME CORPORATION13$274
GlaxoSmithKline, LLC.14$142
Boehringer Ingelheim Pharmaceuticals, Inc.3$65
Takeda Pharmaceuticals U.S.A., Inc.3$46
Viatris Specialty LLC2$37
Regeneron Healthcare Solutions, Inc.1$25
Grifols USA, LLC1$25
United Therapeutics Corporation1$20
Novartis Pharmaceuticals Corporation1$16

Products named: DUPIXENT, NUCALA, GLASSIA, TRELEGY ELLIPTA, YUPELRI, JASCAYD, Prolastin-C Liquid, OFEV.

Industry payments across KS — which companies pay providers there.